Join endocrine experts Ricardo Correa, MD, FACP, FACMQ, FAPCR, FACE; Rajesh Garg, MD, PhD; and Geetha Gopalakrishnan, MD, FACE, as they share valuable tips and success stories on how to talk to patients with diabetes about the importance of vaccinations in diabetes management. Key topics include strategies for addressing barriers in workflows, differences in cultural norms and vaccine hesitancy. AACE endocrine experts share available patient resources along with a wealth of information aimed at enhancing your interactions with patients. 

AACE has revised its policies and adopted a new methodology for guideline and consensus statement development to support the mission to elevate the practice of clinical endocrinology to improve patient care. Join endocrine experts Ricardo Correa, MD, FACP, FACMQ, FAPCR, FACE, Joanna Miragaya, MD, PhD, FACE, and Vin Tangpricha, MD, PhD, FACE, as they dive into the 2023 protocol updates. Key topics include updates to methodology, processes, and policies. Visit https://www.endocrinepractice.org/article/S1530-891X(23)00032-0/fulltext to view the protocol in the May 2023 issue of Endocrine Practice.

Wolfram syndrome (WS) is a rare genetic disorder in which patients develop early-onset diabetes mellitus (DM), optic nerve atrophy, and neurodegeneration, which has no specific treatment available. Listen to endocrine experts Fumihiko Urano, MD, PhD. Samuel E. Schechter Professor of Medicine at Washington University School of Medicine, and Sina Jasim, MD, MPH, Associate Professor of Medicine at Washington University School of Medicine, discuss a new clinical case report on two patients with Wolfram syndrome who were initially diagnosed with type 1 diabetes but were negative for islet autoantibodies. Key topics include the importance of distinguishing between Wolfram syndrome and type 1 diabetes, the significance of the homozygous vs. compound heterozygous pathogenic variants in WFS1 gene, how the management and treatment for Wolfram syndrome differs from that of type 1 diabetes, the current status of therapeutic interventions, and much more. Visit https://doi.org/10.1016/j.aace.2022.01.001 to read the full AACE Clinical Case Report.

Join endocrine experts Karl Nadolsky, DO, DABOM, and Vin Tangpricha, MD, PhD, FACE, as they discuss the 2023 AACE Consensus Statement: Addressing Stigma and Bias in the Diagnosis and Management of Patients with Obesity/Adiposity-Based Chronic Disease and Assessing Bias and Stigmatization as Determinants of Disease Severity. Key topics include defining weight stigma, bias, and internalized weight bias (IWB), empowering patients and our global society to address obesity as a chronic disease, intervention recommendations using the 5A model, and much more. Visit https://www.endocrinepractice.org/article/S1530-891X(23)00335-X/fulltext to view the consensus statement in the June 2023 issue of Endocrine Practice.

Join endocrine experts Irl Hirsch, MD, Susan L. Samson, M.D., Ph.D., FRCPC, FACE, and Vin Tangpricha, MD, PhD, FACE, as they discuss the latest updates to AACE’s 2023 diabetes algorithm, which provides concise guidance to assist health care professionals in clinical decision-making for the management of Type 2 diabetes (T2D). Learn how to leverage the algorithm to improve patient care, how someone’s risk for hypoglycemia impacts their individual target, when to use a complications-centric and glucose-centric approach to choosing first-line therapy for glycemic control, and much more. Visit https://doi.org/10.1016/j.eprac.2023.02.001 to view the full algorithm in the May 2023 issue of Endocrine Practice.

Nonalcoholic fatty liver disease (NAFLD) is a major health problem that is closely linked to the epidemics of obesity and type 2 diabetes mellitus. Join endocrine experts Betul Hatipoglu MD, Professor of Medicine at CWRU School of Medicine, and Medical Director for Diabetes & Obesity Center at University Hospital Cleveland Medical Center, and Sangeeta Kashyap MD, Assistant Chief of Clinical Affairs at New York-Presbyterian/Weill Cornell Medical Center, to learn how to diagnose and manage NAFLD and NASH in primary care and endocrinology clinical settings. Key topics include screening for NAFLD/NASH, and the latest management recommendations including supplements, medications, bariatric surgery, and more.

In this podcast endocrine expert David C. Lieb, MD, FACP, FACE, interviews our AACE 2023 award-winning plenary speakers, Elizabeth N. Pearce, MD, MSc, FACE, Irl Hirsch, MD, and Richard J. Auchus, MD, PhD, FACE, about the latest advancements in thyroid disease, diabetes, and adrenal disease. Key topics include iodine deficiency, adjusting thyroid medication doses, the future of insulin therapy, GMI compared to A1C levels, screening for primary aldosteronism, Cushing's syndrome, adrenal steroid profiling, and more. 

There is varying knowledge among members of the endocrine care team about the vaccines AACE recommends for persons with diabetes that are included in the updated 2022 AACE Diabetes Guideline. In this podcast endocrine expert Vin Tangpricha, MD, PhD, interviews internationally known clinician, epidemiologist, and Interim Dean of Emory University School of Medicine, Carlos del Rio, MD, about the importance of vaccines, how vaccines are made, developed, and approved, and how to use this information to address patients’ questions or hesitancy towards vaccines.

Join endocrine experts S. Sethu K. Reddy, MD, MBA, FRCPC, FACP, MACE, Susan L. Samson, MD, PhD, FRCPC, FACE, and Vin Tangpricha, MD, FACE, as they discuss the 2022 AACE diabetes clinical practice guideline featuring 170 updated and new evidence-based recommendations for the care and management of people with or at risk for diabetes mellitus. Key topics include how to use the guideline in your practice, new content developed on hypoglycemia, secondary diabetes approaches, supplements, social determinants of health, and more. Plus, get an inside sneak peek into the development of a diabetes care algorithm coming soon. Visit https://www.endocrinepractice.org/article/S1530-891X(22)00576-6/fulltext to view the full guideline published in the October 2022 issue of Endocrine Practice.

Join endocrine experts S. Sethu K. Reddy, MD, MBA, FRCPC, FACP, MACE, Susan L. Samson, MD, PhD, FRCPC, FACE, and Vin Tangpricha, MD, FACE, as they discuss the 2022 AACE diabetes clinical practice guideline featuring 170 updated and new evidence-based recommendations for the care and management of people with or at risk for diabetes mellitus. Key topics include how to use the guideline in your practice, new content developed on hypoglycemia, secondary diabetes approaches, supplements, social determinants of health, and more. Plus, get an inside sneak peek into the development of a diabetes care algorithm coming soon. Visit https://www.endocrinepractice.org/article/S1530-891X(22)00576-6/fulltext to view the full guideline published in the October 2022 issue of Endocrine Practice.